Search for Clinical Trial Results

Sponsored By

B Cell Prolymphocytic Leukemia - 14 Studies Found

Status Study
Terminated Study Name: Alvespimycin Hydrochloride in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia
Condition:
  • B-cell Chronic Lymphocytic Leukemia
  • Prolymphocytic Leukemia
  • Drug: alvespimycin hydrochloride

Active, not recruiting Study Name: PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia
Condition:
  • Prolymphocytic Leukemia
  • Recurrent Small Lymphocytic Lymphoma
  • Drug: ibrutinib Patients recei
Active, not recruiting Study Name: Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia or B-Cell Prolymphocytic Leukemia
Condition:
  • Post-transplant Lymphoproliferative Disorder
  • B-Cell Prolymphocytic Leu
    Date: 2014-05-30
    Interventions:
    • Drug: cyclophosphamide Given I
Active, not recruiting Study Name: Ofatumumab and Dinaciclib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia
Condition:
  • Chronic Lymphocytic Leukemia
  • Prolymphocytic Leukemia
  • Recur
    Date: 2012-01-16
    Interventions:
    • Drug: Dinaciclib Given IV
Recruiting Study Name: Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Condition:
  • B-Cell Prolymphocytic Leukemia
  • Recurrent Chronic Lymphocytic Le
    Date: 2013-06-24
    Interventions:
    • Drug: Ibrutinib Given PO
Recruiting Study Name: PCAR-119 Bridge Immunotherapy Prior to Stem Cell Transplant in Treating Patients With CD19 Positive Leukemia and Lymphoma
Condition:
  • Acute Lymphocytic Leukemia
  • Chronic Lymphocytic Leukemia
  • Fo
    Date: 2016-09-02
    Interventions: Biological: anti-CD19 CAR-NK cells The allogeneic NK cells (NK-92 cell line for clinical use) are engine
Recruiting Study Name: Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma
Condition:
  • Acute Lymphocytic Leukemia
  • Chronic Lymphocytic Leukemia
  • Fo
    Date: 2016-07-28
    Interventions: Biological: PCAR-019 (anti-CD19 CAR-T cells) Other Name: chimeric antigen receptor T cells with specific
Recruiting Study Name: CAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma
Condition:
  • Acute Lymphocytic Leukemia
  • Chronic Lymphocytic Leukemia
  • Fo
    Date: 2016-06-28
    Interventions: Biological: PCAR-019 (anti-CD19 CAR-T cells) Other Name: chimeric antigen receptor T cells with specific
Recruiting Study Name: Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
Condition:
  • B-Cell Prolymphocytic Leukemia
  • Hypodiploidy
  • Procedure: Allogeneic Bone Marrow Transplantation

Active, not recruiting Study Name: Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia
Condition:
  • B-Cell Prolymphocytic Leukemia
  • Chronic Lymphocytic Leukemia Date: 2003-05-06
    Interventions:
    • Drug: Cyclosporine Given PO
Next >>>